Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

Key Updates

Executive summary: Europe Equity Growth Fund (UQ2B.F) fell to 343.20 EUR, down 2.39% since the 19 October 2026 report (351.61 EUR). The move equals 2.1 ATR and occurred with no news for 7 days. The bearish assessment from the prior report is confirmed, and no new fundamental information alters the thesis.

  • Price change since 19 October report: -2.39% (351.61 EUR to 343.20 EUR). Since the 1 October report (357.82 EUR) the cumulative decline is about -4.09%.
  • Short-term momentum is negative on every horizon: 1d -0.91%, 5d -2.72%, 1m -3.73%.
  • The 5-day decline accounts for most of the 1-month decline, so the selling has accelerated recently.
  • No news articles were provided, so the decline cannot be attributed to a specific event.

Current Trend

The fund is in a downtrend. YTD performance is -1.54%, and 6-month performance is -0.41%. The implied year-start level is about 348.57 EUR, and the price of 343.20 EUR is below it. The implied level six months ago is about 344.61 EUR, also above the current price. The 1-month decline of -3.73% implies a level near 356.50 EUR a month ago, which is the nearest overhead reference.

Investment Thesis

The fund offers diversified exposure to European growth equities. The provided data contains no holdings, valuation, earnings or macro information, so the thesis cannot be tested against fundamentals. The assessment therefore rests on price behaviour and the prior reports. The 19 October report leaned negative, citing a price below its 50-day, 200-day and 40-week averages and a weekly downtrend.

Thesis Status

The negative bias from the 19 October report is intact and has strengthened on price evidence. The fund lost a further 2.39% and moved to 2.1 ATR below the prior report level, against an earlier trigger of 1.6 ATR. No positive catalyst has emerged to challenge the trend. Status: negative, confirmed. A recovery above the implied 6-month reference (about 344.61 EUR) and then the implied year-start level (about 348.57 EUR) would be the first signs of stabilisation.

Key Drivers

No news articles were provided for this period (0 articles, none for 7 days), so no source links are available. The drivers observable in the data are:

  • Persistent downside momentum over the 1d, 5d and 1m horizons.
  • An absence of company-specific or market-wide catalysts in the data set.
  • Three consecutive reports showing declines (1 October report: -4.28% since the prior report; 19 October report: -1.7%; this update: -2.39%).

Technical Analysis

  • Price: 343.20 EUR, down -0.91% on the day.
  • Volatility: the -2.4% move equals 2.1 ATR, implying a daily ATR of roughly 1.1% of price. This is a larger-than-normal move compared with 1.6 ATR in the prior report.
  • Trend structure: as of 19 October the price was below the 50-day, 200-day and 40-week averages, and the weekly trend was down. Updated moving-average values were not provided, but the price has since moved lower.
  • Resistance (implied by performance data): about 344.61 EUR (6-month reference), about 348.57 EUR (year-start level) and about 356.50 EUR (1-month reference). 351.61 EUR (19 October report level) is additional resistance.
  • Support: no verified support level is available in the provided data. The price is at the lowest of the reference levels derived above, so there is no nearby data-based support.

Bull Case

No source URLs are available, as the provided data contains no news articles. Arguments rest on the provided price data, ranked from strongest to weakest.

  • The longer-term drawdown is modest: 6m -0.41% and YTD -1.54%. The fund remains close to its levels from earlier in the year. Source: provided price data (no URL).
  • The decline occurred without any negative news for 7 days, and the data shows no company-specific deterioration. Source: provided news data, 0 articles (no URL).
  • Recovering the implied 6-month reference of about 344.61 EUR, only 0.4% above the current price, would neutralise the 6-month performance. Source: provided price data (no URL).
  • The move of 2.1 ATR is large relative to recent volatility, so some partial retracement is possible. Source: analysis trigger data (no URL).
  • A return to the implied year-start level of about 348.57 EUR requires a gain of about 1.6%, which would restore flat YTD performance. Source: provided price data (no URL).

Bear Case

No source URLs are available, as the provided data contains no news articles. Arguments rest on the provided price data and prior reports, ranked from strongest to weakest.

  • Negative momentum is broad: 1d -0.91%, 5d -2.72%, 1m -3.73%. Source: provided price data (no URL).
  • The downtrend is persistent: -4.28%, then -1.7%, then -2.39% across successive reports, a cumulative decline of about -4.09% since 1 October. Source: previous reports (no URL).
  • The weekly trend was down with the price below the 50-day, 200-day and 40-week averages as of 19 October, and the price has since fallen further. Source: report of 19 October 2026 (no URL).
  • The fund is down -1.54% YTD, trades below the implied year-start level of about 348.57 EUR, and shows -0.41% over 6 months. Source: provided price data (no URL).
  • Selling has accelerated, since most of the 1-month decline occurred in the last 5 days, and the data holds no positive catalyst to counter it. Source: provided price and news data (no URL).

Europe Equity Growth Fund (UQ2B.F) trades at 351.61 EUR on October 19, 2026, below its 50-day, 200-day and 40-week averages, so the weekly trend is down. The balance of evidence leans negative for the next two to six weeks, with medium conviction: two of four points line up. The fund fell less than the S&P 500 over the last five days, but it has lagged the index over 50 days, and rallies keep stalling under 353.76 EUR.

Why it matters

No news item in the material explains this move. The recent headlines concern Schroders Capital's CEO leaving amid the Nuveen takeover, a securities class action against Bloom Energy, and Marblegate buying the Fed's Covid-era loans. None is tied to a disclosed holding of this basket, and no flow data or holdings changes were reported. The price action therefore has to be judged on its own: a fund that peaked and has drifted lower without a catalyst.

The peak came on September 21, 2026, at a close of 359.81 EUR. That was a strong session for European equities: Reuters reported the STOXX 600 up 0.8% to 640.55, led by technology and a fourth straight decline in oil prices. The fund has since given back 2.3% from that close. The theme's good news was already in the price on the day it peaked, and buyers have not carried it higher since.

Against the market, this week looks better than the longer record. Over five days the fund is down 0.78% while SPY is down 1.97%, so the fund held up better than the US market in a falling tape. Over one month it is up 0.63% against 1.22% for SPY, and year to date it is up 0.87% against 11.93%. Over 50 days it trails the S&P 500 by 2.7%, and that lag is one of the two reasons behind the negative reading. No sector ETF comparison is available, so the move cannot be split between a sector and the basket itself.

There is no debate to report: no articles argue for or against the fund, and there are no analyst ratings or price targets. Valuation is not a useful lens for a fund, and the data carries no figure for the basket's holdings. The evidence is the price, the averages and the relative performance against the S&P 500.

What the evidence says

For the long term, the thesis is weakened rather than broken. The price is below its 40-week average, which defines the weekly downtrend. It is also 6.18% under the 52-week high of 374.76 EUR and 10.63% above the low of 317.82 EUR. Over six months the fund is down 0.97%, so it has gone nowhere. The phase looks like a stalled advance turning into a downtrend. The price sits just under the 200-day average at 354.71 EUR and under the 50-day at 358.56 EUR.

For the next two to six weeks the balance of evidence leans negative, at medium conviction, two of four points. The daily trend runs with the weekly downtrend, and the fund lags the S&P 500 over 50 days. Volume supports the sellers: it is 48.1% above its 20-day average while the price slips. The reading stops at medium because only two of the four conditions are met.

The strongest case against it is that the fund is not collapsing. It has fallen less than SPY this week and is still up over one month. The RSI at 36.14 is close to oversold, where short-term bounces tend to start, and round-number support at 350 EUR sits just below the price. A market rebound could lift the fund through 353.76 EUR. That is why conviction is not higher. It does not tip the balance, because each rally so far has met sellers at the same zone and the averages still slope against the fund.

Levels that matter

In a downtrend the structure holds below 353.76 EUR, a swing zone where sellers have appeared on previous rallies. The trend would end above 358.56 EUR, the 50-day average. A weekly close there would put the price back above the average that has capped the fund since the September peak. Above that sit 361.96 EUR and then 374.59 EUR, the old swing zones near the 52-week high.

The breakout level is a daily close below 350.0 EUR, the round-number support. From there the math points to 336.0 EUR, a swing zone, at 3.0 to 1 reward-to-risk, and then to the 52-week low at 317.82 EUR at 6.8 to 1. A downside breakout would be wrong above 354.74 EUR, which is the 353.76 EUR swing zone plus a quarter of the 3.91 ATR. The first target just reaches the 3 to 1 that makes a breakout worth the risk, and the second clears it comfortably. Between them lies 325 EUR as a round-number pause.

What would change the picture

The rule is a weekly close above 358.56 EUR, the 50-day average. That would put the fund back above the level that has capped every bounce and would end the near-term downtrend reading. The non-price fact that would make it stick is evidence that money is returning to the theme, such as sustained net inflows into the fund or stronger results from the basket's largest holdings. The news so far shows neither.

What to watch

  • The 350 EUR level: a daily close below it opens the path to 336 EUR.
  • The 353.76 EUR swing zone and the 354.71 EUR 200-day average, where rallies have faded so far.
  • The weekly close against 358.56 EUR, the 50-day average and the line between a downtrend and a recovery.
  • Third-quarter results from the basket's major European growth holdings. No dates appear in the material, so the schedule has to come from the holdings list.
  • Fund flows and any change to the holdings. None have been reported.
  • The S&P 500 after its 1.97% five-day drop. The fund has held up better than the index this week, and a recovery in the index that the fund fails to join would add to the lag of 2.7% over 50 days.
CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.